Placental Stem Cell Therapy Market

Placental Stem Cell Therapy Market (Application: Hematologic Malignancies and Disorders, Congenital Immunodeficiency Disorders, Metabolic Disorders, and Neurological Disorders; and End User: Hospitals & Specialty Clinics, Clinical Research Organizations, and Research Institutes & Academies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030

Placental Stem Cell Therapy Holds Promising Potentials in Treatment of Coronavirus

The placental mesenchymal stem cells therapy is gaining popularity as a potential solution for the treatment of severe COVID-19. The Institute of Cell Therapy is acquiring recognition for successfully curing COVID-19 patients with the help of placental stem cells lacking ACE-2 receptor, which hold promising potentials in the treatment of coronavirus pneumonia. As such, worldwide inoculation of coronavirus vaccines from India has caused a slowdown in research activities of the placental stem cell therapy market.

Stakeholders in the placental stem cell therapy market are anticipated to continue their research for minimizing the impacts of future coronavirus-like outbreaks. They are boosting clinical trials to evaluate the efficacy of stem cells of different types for the treatment of COVID-19 in China.

placental stem cell therapy market segmentation

Robust Analytics, Independent Measurement Systems Improve Consistency in Production

The placental stem cell therapy market stood at US$ 0.5 Bn in 2019 and is expected to cross a revenue of US$ 4.4 Bn by the end of 2030. However, manufacturing is a consistent challenge for stem cell companies across various industries such as for neurological disorders, hematologic malignancies, and congenital immunodeficiency disorders. Hence, companies are mastering batch-to-batch consistency of C to monitor results.

Companies in the placental stem cell therapy market are focusing on producing cells in a consistent and quality manner. ReNeuron - a developer of therapeutics from retina specific stem cells is increasing efforts to strike the right balance between science and art to maintain consistency in cell production for the treatment of retinitis pigmentosa (RP).

MSC-based Therapies Help in Treatment of Respiratory Diseases

Mesenchymal stromal cell (MSC)-based therapies are appearing as new therapeutic strategies for lung diseases. Idiopathic pulmonary fibrosis (IPF), cystic fibrosis (CF), and acute respiratory distress syndrome (ARDS), among others, have triggered the demand for mesenchymal stromal cell-based therapies. MSCs are being publicized as multipotent cells with immune modulatory and regenerative properties. This explains why the placental stem cell therapy market is estimated to progress at an astonishing CAGR of 20% during the assessment period.

The acute respiratory distress syndrome is emerging as an ideal target for the mesenchymal stromal cell-based therapy, since MSCs act as immunomodulatory cells via rapid-acting paracrine effects. Companies in the placental stem cell therapy market are increasing efforts to conduct pre-clinical studies that demonstrate the efficacy of MSCs for ARDS.

Hepatocytes Generated from Stem Cells Show Potential in Treatment of Congenital Metabolic Diseases

Since congenital metabolic diseases are associated with morbidity due to invasive procedures such as liver transplant, healthcare companies in the placental stem cell therapy market are capitalizing on this opportunity to offer regenerative cell therapies. Regenerative therapy using hepatocytes generated from stem cells has the potential to treat congenital metabolic diseases. This technique is gaining popularity as a less invasive cell replacement approach, suitable for the treatment of congenital metabolic diseases.

Embryonic stem cells are prone to risks of tumorigenicity and difficulties with cell expansion, owing to the number needed for the anticipated therapeutic effect. Human amniotic epithelial cells (hAECs) have caught the attention of companies in the placental stem cell therapy market to treat congenital metabolic diseases.

Combined Transplantation of Allogeneic Stem Cells Being Used to Cure Neurological Diseases

Cell therapy of neurological diseases is gaining momentum in the placental stem cell therapy market. Stem and progenitor cells are showing positive therapeutic results in animal models of neurological disorders within clinical trials. It has been found that each cell being tested has its advantages and drawbacks, owing to unique molecular mechanisms of action. This has led to the concept of combined transplantation of two or more cells.

The transplantation of various types of autologous or allogeneic stem/progenitor cells, including embryonic and induced pluripotent stem cells, has shown promising therapeutic outcomes in animal models of neurological diseases. Such findings are translating into revenue opportunities for companies in the placental stem cell therapy market.

placental stem cell therapy market infographic

Analysts’ Viewpoint

Mesenchymal stem cells are emerging as powerful immunomodulators that are playing a key role in advancements made for the treatment of severe COVID-19 patients. MSC-based therapies hold future prospects for companies in the placental stem cell therapy market to create therapeutics for bronchopulmonary dysplasia (BPD) in infants born prematurely. MSCs have proven paracrine activity, which helps migrate toward inflamed sites and improves outcomes in patients suffering from neurological disorders. Ethical issues and immune mediated rejection of transplanted cells are posing as hurdles in the treatment of congenital metabolic diseases. Hence, companies should increase the production of human amniotic epithelial cells (hAECs) that are emerging as an alternative to hepatocyte transplantation (HT) for patients suffering from congenital metabolic diseases.

Placental Stem Cell Therapy Market: Overview

  • According to Transparency Market Research’s latest research report on the global placental stem cell therapy market for the historical period 20182019 and the forecast period of 20202030, prominence in treatment of age-related disorders/diseases and increase in awareness about stem cell therapies are projected to drive the global placental stem cell therapy market in the near future
  • According to the report, the global placental stem cell therapy market was valued at US$ 0.5 Bn in 2019. It is anticipated to expand at a CAGR of 20% from 2020 to 2030.

Regenerative Ability to Develop into Other Types of Cells to Drive Global Market

  • Placental therapy is being used to promote recovery from diseases and tissue regeneration since the early 1900s. Since then, placental stem cell therapy has been applied in various clinical applications, as it has exhibited remarkable therapeutic attributes, ranging from anti-oxidant, anti-microbial, anti-inflammatory, pain reduction, hair growth promotion, health improvement, and cellular proliferation to tissue regeneration and wound healing properties in vivo. This review further summarizes historical aspects, cellular mechanism, nutrient content, and therapeutics properties of the placenta.
  • Placental stem cells offer the potential to treat rare diseases or conditions for which few treatments exist. Sometimes called the body’s “master cells,” these cells can develop into blood, brain, bones, and all of the body’s organs.
  • These have the potential to repair, restore, replace, and regenerate cells, and could possibly be used to treat several medical conditions and diseases
  • Placental stem cell therapy is quite useful for the cure of diseases such as Alzheimer’s disease
  • According to the WHO, worldwide, around 50 million people have dementia and nearly 10 million new cases are recorded every year. Alzheimer's disease is a highly common form of dementia and contributes to 60% to 70% of cases.

Ease of Procurement

  • Placenta is a vascular organ with a known duration of life, and is only developed during the occurrence of pregnancy. It attaches to the uterine wall and the umbilical cord, which connects between the mother and the fetus, thereby supporting the growth and development of the fetus.
  • Placenta plays an important role in transfer of gases, nutrients, and removal of waste products during pregnancy, which is vital for the sustenance of the fetus
  • Placenta stem cells also provide additional benefit as compared to that offered by other tissues. These cells are easy to procure, with no harm to the mother or the baby. There are also no ethical issues associated with obtaining placenta, as it is considered a biological waste after birth.
  • Placenta has high cell yield and is less exposed to infection, as it comes from an infection-naïve environment. This makes rendering any disease transmission less likely. This factor is considered a major driver of the placental stem cell therapy market.
  • Rise in the number of storage banks and the awareness among people are key factors boosting the adoption of placental stem cell therapy

Increase in Awareness about Stem Cell Therapies

  • Several programs have been conducted to spread awareness about stem cell therapies and educate about the ethical aspects in the field
  • Every October, the global stem cell community comes together to promote appreciation and understanding of stem cell research on Stem Cell Awareness Day
  • In emerging countries, such as India, awareness and acceptance for stem cell therapy are increasing rapidly
  • In 2016, NeuroGen Brain and Spine Institute conducted awareness programs about stem cell therapy in Karnataka (India) and other neighboring states. Thus far, the institute has successfully treated over 800 patients.

Placental Stem Cell Therapy Market: Competition Landscape

  • This report profiles major players operating in the global placental stem cell therapy market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global placental stem cell therapy market is moderately fragmented, with the presence of a large number of leading players in the global market and several small players in regional markets. Top players hold a major share of the global placental stem cell therapy market.
  • Prominent players operating in the global placental stem cell therapy market include
    • Lifebank Stem Cell Banking
    • Celularity, Inc.
    • Americord Registry
    • ReeLabs Pvt. Ltd.
    • Pluristem Therapeutics, Inc.
    • Mesoblast Limited
    • ReNeuron Group plc
    • Athersys, Inc.
  • The report on the global placental stem cell therapy market discusses individual strategies, followed by company profiles of providers of stem cell therapy. The competition landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global placental stem cell therapy market.

Placental Stem Cell Therapy Market – Segmentation

Application
  • Hematologic Malignancies and Disorders
  • Congenital Immunodeficiency Disorders
  • Metabolic Disorders
  • Neurological Disorders
End User
  • Hospitals & Specialty Clinics
  • Clinical Research Organizations
  • Research Institutes & Academies
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America

Frequently Asked Questions

What is the total market worth of placental stem cell therapy market?

Placental stem cell therapy market is expected to cross a revenue of US$ 4.4 Bn by the end of 2030

What is the anticipated CAGR of the placental stem cell therapy market in the forecast period?

Placental stem cell therapy market is projected to expand at a CAGR of 20% from 2020 to 2030

What are the key driving factors for the growth of the placental stem cell therapy market?

Placental stem cell therapy market is driven by increase in awareness about stem cell therapies

Which is the rising prominent segment in the placental stem cell therapy market?

The neurological disorders segment held a significant share of the global placental stem cell therapy market

Who are the key players in the global placental stem cell therapy market?

Key players operating in the global placental stem cell therapy market include Lifebank Stem Cell Banking, Celularity, Inc., Americord Registry, ReeLabs Pvt. Ltd., Pluristem Therapeutics, Inc.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Placental Stem Cell Therapy Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Application Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Placental Stem Cell Therapy Market Analysis and Forecast, 2018–2030

            4.4.1. Market Revenue Projections (US$ Mn)

    5. Key Insights

        5.1. Supply Chain Analysis

            5.1.1. Placental Stem Cells Collection & Isolation

            5.1.2. Cell processing & Cryo-preservation

            5.1.3. Cell Differentiation

            5.1.4. Cell Culture and Expansion

        5.2. Pipeline Analysis

        5.3. Regulatory Scenario, by Region/globally

        5.4. Reimbursement Scenario, by Region/globally

        5.5. Pricing Analysis, 2019

        5.6. COVID-19 Pandemic Impact on Industry

    6. Global Placental Stem Cell Therapy Market Analysis and Forecast, by Application

        6.1. Introduction & Definition

        6.2. Key Findings / Developments

        6.3. Global Placental Stem Cell Therapy Market Value Forecast, by Application, 2018–2030

            6.3.1. Hematologic Malignancies and Disorders

            6.3.2. Congenital Immunodeficiency Disorders

            6.3.3. Metabolic Disorders

            6.3.4. Neurological Disorders

            6.3.5. Others

        6.4. Global Placental Stem Cell Therapy Market Attractiveness Analysis, by Application

    7. Global Placental Stem Cell Therapy Market Analysis and Forecast, by End-user

        7.1. Introduction & Definition

        7.2. Key Findings / Developments

        7.3. Global Placental Stem Cell Therapy Market Value Forecast, by End-user, 2018–2030

            7.3.1. Hospitals & Specialty Clinics

            7.3.2. Clinical Research Organizations 

            7.3.3. Research Institutes & Academies

        7.4. Global Placental Stem Cell Therapy Market Attractiveness Analysis, by End-user

    8. Global Placental Stem Cell Therapy Market Analysis and Forecast, by Region

        8.1. Key Findings

        8.2. Global Placental Stem Cell Therapy Market Value Forecast, by Region

            8.2.1. North America 

            8.2.2. Europe 

            8.2.3. Asia Pacific 

            8.2.4. Latin America 

            8.2.5. Middle East & Africa 

        8.3. Global Placental Stem Cell Therapy Market Attractiveness Analysis, by Country/Region

    9. North America Placental Stem Cell Therapy Market Analysis and Forecast

        9.1. Introduction

            9.1.1. Key Findings

        9.2. North America Placental Stem Cell Therapy Market Value Forecast, by Application, 2018–2030

            9.2.1. Hematologic Malignancies and Disorders

            9.2.2. Congenital Immunodeficiency Disorders

            9.2.3. Metabolic Disorders

            9.2.4. Neurological Disorders

            9.2.5. Others

        9.3. North America Placental Stem Cell Therapy Market Value Forecast, by End-user, 2018–2030

            9.3.1. Hospitals & Specialty Clinics

            9.3.2. Clinical Research Organizations

            9.3.3. Research Institutes & Academies

        9.4. North America Placental Stem Cell Therapy Market Value Forecast, by Country, 2018–2030

            9.4.1. U.S.

            9.4.2. Canada

        9.5. North America Placental Stem Cell Therapy Market Attractiveness Analysis 

            9.5.1. By Application

            9.5.2. By End-user

            9.5.3. By Country

    10. Europe Placental Stem Cell Therapy Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Europe Placental Stem Cell Therapy Market Value Forecast, by Application, 2018–2030

            10.2.1. Hematologic Malignancies and Disorders

            10.2.2. Congenital Immunodeficiency Disorders

            10.2.3. Metabolic Disorders

            10.2.4. Neurological Disorders

            10.2.5. Others

        10.3. Europe Placental Stem Cell Therapy Market Value Forecast, by End-user, 2018–2030

            10.3.1. Hospitals & Specialty Clinics

            10.3.2. Clinical Research Organizations

            10.3.3. Research Institutes & Academies

        10.4. Europe Placental Stem Cell Therapy Market Value Forecast, by Country/Sub-region, 2018–2030

            10.4.1. Germany

            10.4.2. U.K.

            10.4.3. France

            10.4.4. Spain

            10.4.5. Italy

            10.4.6. Rest of Europe

        10.5. Europe Placental Stem Cell Therapy Market Attractiveness Analysis

            10.5.1. By Application

            10.5.2. By End-user

            10.5.3. By Country/Sub-region

    11. Asia Pacific Placental Stem Cell Therapy Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Asia Pacific Placental Stem Cell Therapy Market Value Forecast, by Application, 2018–2030

            11.2.1. Hematologic Malignancies and Disorders

            11.2.2. Congenital Immunodeficiency Disorders

            11.2.3. Metabolic Disorders

            11.2.4. Neurological Disorders

            11.2.5. Others

        11.3. Asia Pacific Placental Stem Cell Therapy Market Value Forecast, by End-user, 2018–2030

            11.3.1. Hospitals & Specialty Clinics

            11.3.2. Clinical Research Organizations

            11.3.3. Research Institutes & Academies

        11.4. Asia Pacific Placental Stem Cell Therapy Market Value Forecast, by Country/Sub-region, 2018–2030

            11.4.1. China

            11.4.2. Japan

            11.4.3. India

            11.4.4. Australia & New Zealand

            11.4.5. Rest of Asia Pacific

        11.5. Asia Pacific Placental Stem Cell Therapy Market Attractiveness Analysis

            11.5.1. By Application

            11.5.2. By End-user

            11.5.3. By Country/Sub-region

    12. Latin America Placental Stem Cell Therapy Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Latin America Placental Stem Cell Therapy Market Value Forecast, by Application, 2018–2030

            12.2.1. Hematologic Malignancies and Disorders

            12.2.2. Congenital Immunodeficiency Disorders

            12.2.3. Metabolic Disorders

            12.2.4. Neurological Disorders

            12.2.5. Others

        12.3. Latin America Placental Stem Cell Therapy Market Value Forecast, by End-user, 2018–2030

            12.3.1. Hospitals & Specialty Clinics

            12.3.2. Clinical Research Organizations

            12.3.3. Research Institutes & Academies

        12.4. Latin America Placental Stem Cell Therapy Market Value Forecast, by Country/Sub-region, 2018–2030

            12.4.1. Brazil

            12.4.2. Mexico

            12.4.3. Rest of Latin America

        12.5. Latin America Placental Stem Cell Therapy Market Attractiveness Analysis 

            12.5.1. By Application

            12.5.2. By End-user

            12.5.3. By Country//Sub-region

    13. Middle East & Africa Placental Stem Cell Therapy Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Middle East & Africa Placental Stem Cell Therapy Market Value Forecast, by Application, 2018–2030

            13.2.1. Hematologic Malignancies and Disorders

            13.2.2. Congenital Immunodeficiency Disorders

            13.2.3. Metabolic Disorders

            13.2.4. Neurological Disorders

            13.2.5. Others

        13.3. Middle East & Africa Placental Stem Cell Therapy Market Value Forecast, by End-user, 2018–2030

            13.3.1. Hospitals & Specialty Clinics

            13.3.2. Clinical Research Organizations

            13.3.3. Research Institutes & Academies

        13.4. Middle East & Africa Placental Stem Cell Therapy Market Value Forecast, by Country/Sub-region, 2018–2030

            13.4.1. GCC Countries

            13.4.2. South Africa

            13.4.3. Rest of Middle East & Africa

        13.5. Middle East & Africa Placental Stem Cell Therapy Market Attractiveness Analysis 

            13.5.1. By Application

            13.5.2. By End-user

            13.5.3. By Country/Sub-region

    14. Competition Landscape

        14.1. Market Player - Competition Matrix (by tier and size of companies)

        14.2. Market Share Analysis, by Company, 2019

        14.3. Company Profiles

            14.3.1. Lifebank Stem Cell Banking

                14.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)

                14.3.1.2. Product Portfolio

                14.3.1.3. SWOT Analysis

                14.3.1.4. Strategic Overview

            14.3.2. Celularity, Inc.

                14.3.2.1 Company Overview (HQ, Business Segments, Employee Strength)

                14.3.2.2. Product Portfolio

                14.3.2.3. SWOT Analysis

                14.3.2.4. Strategic Overview

            14.3.3. Americord Registry

                14.3.3.1 Company Overview (HQ, Business Segments, Employee Strength)

                14.3.3.2. Product Portfolio

                14.3.3.3. SWOT Analysis

                14.3.3.4. Strategic Overview

            14.3.4. ReeLabs Pvt. Ltd.

                14.3.4.1 Company Overview (HQ, Business Segments, Employee Strength)

                14.3.4.2. Product Portfolio

                14.3.4.3. SWOT Analysis

                14.3.4.4. Strategic Overview

            14.3.5. Pluristem Therapeutics, Inc.

                14.3.5.1 Company Overview (HQ, Business Segments, Employee Strength)

                14.3.5.2. Product Portfolio

                14.3.5.3. SWOT Analysis

                14.3.5.4. Strategic Overview

            14.3.6. Mesoblast Limited

                14.3.6.1 Company Overview (HQ, Business Segments, Employee Strength)

                14.3.6.2. Product Portfolio

                14.3.6.3. SWOT Analysis

                14.3.6.4. Strategic Overview

            14.3.7. ReNeuron Group plc 

                14.3.7.1 Company Overview (HQ, Business Segments, Employee Strength)

                14.3.7.2. Product Portfolio

                14.3.7.3. SWOT Analysis

                14.3.7.4. Strategic Overview

            14.3.8. Athersys, Inc.

                14.3.8.1 Company Overview (HQ, Business Segments, Employee Strength)

                14.3.8.2. Product Portfolio

                14.3.8.3. SWOT Analysis

                14.3.8.4. Strategic Overview

            14.3.9. Other Prominent Key Players

    List of Tables

    Table 1: Global Placental Stem Cell Therapy Market Value (US$ Mn) Forecast, by Application, 2018–2030

    Table 2: Global Placental Stem Cell Therapy Market Value (US$ Mn) Forecast, by End-user, 2018–2030

    Table 3: Global Placental Stem Cell Therapy Market Value (US$ Mn) Forecast, by Region, 2018–2030

    Table 4: North America Placental Stem Cell Therapy Market Value (US$ Mn) Forecast, by Country, 2018–2030

    Table 5: North America Placental Stem Cell Therapy Market Value (US$ Mn) Forecast, by Application, 2018–2030

    Table 6: North America Placental Stem Cell Therapy Market Value (US$ Mn) Forecast, by End-user, 2018–2030

    Table 7: Europe Placental Stem Cell Therapy Market Value (US$ Mn) Forecast, by Country, 2018–2030

    Table 8: Europe Placental Stem Cell Therapy Market Value (US$ Mn) Forecast, by Application, 2018–2030

    Table 9: Europe Placental Stem Cell Therapy Market Value (US$ Mn) Forecast, by End-user, 2018–2030

    Table 10: Asia Pacific Placental Stem Cell Therapy Market Value (US$ Mn) Forecast, by Country, 2018–2030

    Table 11: Asia Pacific Placental Stem Cell Therapy Market Value (US$ Mn) Forecast, by Application, 2018–2030

    Table 12: Asia Pacific Placental Stem Cell Therapy Market Value (US$ Mn) Forecast, by End-user, 2018–2030

    Table 13: Latin America Placental Stem Cell Therapy Market Value (US$ Mn) Forecast, by Country, 2018–2030

    Table 14: Latin America Placental Stem Cell Therapy Market Value (US$ Mn) Forecast, by Application, 2018–2030

    Table 15: Latin America Placental Stem Cell Therapy Market Value (US$ Mn) Forecast, by End-user, 2018–2030

    Table 16: Middle East & Africa Placental Stem Cell Therapy Market Value (US$ Mn) Forecast, by Country, 2018–2030

    Table 17: Middle East & Africa Placental Stem Cell Therapy Market Value (US$ Mn) Forecast, by Application, 2018–2030

    Table 18: Middle East & Africa Placental Stem Cell Therapy Market Value (US$ Mn) Forecast, by End-user, 2018–2030

    List of Figures

    Figure 1: Global Placental Stem Cell Therapy Market Value (US$ Mn) Forecast, 2018–2030

    Figure 2: Global Placental Stem Cell Therapy Market Value Share, by Application (2019)

    Figure 3: Global Placental Stem Cell Therapy Market Value Share, by End-user (2019)

    Figure 4: Global Placental Stem Cell Therapy Market Value Share, by Region (2019)

    Figure 5: Global Placental Stem Cell Therapy Market Value Share Analysis, by Application, 2019 and 2030

    Figure 6: Global Placental Stem Cell Therapy Market Attractiveness Analysis, by Application, 2020–2030

    Figure 7: Global Placental Stem Cell Therapy Market Value (US$ Mn), by Hematologic Malignancies and Disorders, 2018–2030

    Figure 8: Global Placental Stem Cell Therapy Market Value (US$ Mn), by Congenital Immunodeficiency Disorders, 2018–2030

    Figure 9: Global Placental Stem Cell Therapy Market Value (US$ Mn), by Metabolic Disorders, 2018–2030

    Figure 10: Global Placental Stem Cell Therapy Market Value (US$ Mn), by Neurological Disorders, 2018–2030

    Figure 11: Global Placental Stem Cell Therapy Market Value (US$ Mn), by Others, 2018–2030

    Figure 12: Global Placental Stem Cell Therapy Market Value Share Analysis, by End-user, 2019 and 2030

    Figure 13: Global Placental Stem Cell Therapy Market attractiveness index Analysis, by End-user, 2020–2030

    Figure 14: Global Placental Stem Cell Therapy Market Value (US$ Mn), by Hospitals & Specialty Clinics, 2018–2030

    Figure 15: Global Placental Stem Cell Therapy Market Value (US$ Mn), by Clinical Research Organizations, 2018–2030

    Figure 16: Global Placental Stem Cell Therapy Market Value (US$ Mn), by Research Institutes & Academies, 2018–2030

    Figure 17: Global Placental Stem Cell Therapy Market Value Share Analysis, by Region, 2019 and 2030

    Figure 18: Global Placental Stem Cell Therapy Market Attractiveness Analysis, by Region, 2020–2030

    Figure 19: North America Placental Stem Cell Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

    Figure 20: North America Placental Stem Cell Therapy Market Value Share, by Country, 2019–2030

    Figure 21: North America Placental Stem Cell Therapy Market Attractiveness, by Country, 2019–2030

    Figure 22: North America Placental Stem Cell Therapy Market Value Share (%), by Application, 2019 and 2030

    Figure 23: North America Placental Stem Cell Therapy Market Attractiveness Analysis, by Application, 2020–2030

    Figure 24: North America Placental Stem Cell Therapy Market Value Share (%), by End-user, 2019 and 2030

    Figure 25: North America Placental Stem Cell Therapy Market Attractiveness Analysis, by End-user, 2020–2030

    Figure 26: Europe Placental Stem Cell Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

    Figure 27: Europe Placental Stem Cell Therapy Market Value Share, by Country, 2019–2030

    Figure 28: Europe Placental Stem Cell Therapy Market Attractiveness, by Country, 2019–2030

    Figure 29: Europe Placental Stem Cell Therapy Market Value Share (%), by Application, 2019 and 2030

    Figure 30: Europe Placental Stem Cell Therapy Market Attractiveness Analysis, by Application, 2020–2030

    Figure 31: Europe Placental Stem Cell Therapy Market Value Share (%), by End-user, 2019 and 2030

    Figure 32: Europe Placental Stem Cell Therapy Market Attractiveness Analysis, by End-user, 2020–2030

    Figure 33: Asia Pacific Placental Stem Cell Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

    Figure 34: Asia Pacific Placental Stem Cell Therapy Market Value Share, by Country, 2019–2030

    Figure 35: Asia Pacific Placental Stem Cell Therapy Market Attractiveness, by Country, 2019–2030

    Figure 36: Asia Pacific Placental Stem Cell Therapy Market Value Share (%), by Application, 2019 and 2030

    Figure 37: Asia Pacific Placental Stem Cell Therapy Market Attractiveness Analysis, by Application, 2020–2030

    Figure 38: Asia Pacific Placental Stem Cell Therapy Market Value Share (%), by End-user, 2019 and 2030

    Figure 39: Asia Pacific Placental Stem Cell Therapy Market Attractiveness Analysis, by End-user, 2020–2030

    Figure 40: Latin America Placental Stem Cell Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

    Figure 41: Latin America Placental Stem Cell Therapy Market Value Share, by Country, 2019–2030

    Figure 42: Latin America Placental Stem Cell Therapy Market Attractiveness, by Country, 2019–2030

    Figure 43: Latin America Placental Stem Cell Therapy Market Value Share (%), by Application, 2019 and 2030

    Figure 44: Latin America Placental Stem Cell Therapy Market Attractiveness Analysis, by Application, 2020–2030

    Figure 45: Latin America Placental Stem Cell Therapy Market Value Share (%), by End-user, 2019 and 2030

    Figure 46: Latin America Placental Stem Cell Therapy Market Attractiveness Analysis, by End-user, 2020–2030

    Figure 47: Middle East Africa Placental Stem Cell Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

    Figure 48: Middle East Africa Placental Stem Cell Therapy Market Value Share, by Country, 2019–2030

    Figure 49: Middle East Africa Placental Stem Cell Therapy Market Attractiveness, by Country, 2019–2030

    Figure 50: Middle East Africa Placental Stem Cell Therapy Market Value Share (%), by Application, 2019 and 2030

    Figure 51: Middle East Africa Placental Stem Cell Therapy Market Attractiveness Analysis, by Application, 2020–2030

    Figure 52: Middle East Africa Placental Stem Cell Therapy Market Value Share (%), by End-user, 2019 and 2030

    Figure 53: Middle East Africa Placental Stem Cell Therapy Market Attractiveness Analysis, by End-user, 2020–2030

    Figure 54: Market Position Analysis, 2018, by Tier and Size of the Company

Copyright © Transparency Market Research, Inc. All Rights reserved